SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 0.85 |
Enterprise Value ($M) | 0.85 |
Book Value ($M) | 0.00 |
Book Value / Share | 0.00 |
Price / Book | n/a |
NCAV ($M) | 0.00 |
NCAV / Share | 0.00 |
Price / NCAV | n/a |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | 0.00 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | n/a |
Current Ratio | n/a |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 0.00 |
Assets | 0.00 |
Liabilities | 0.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Carlyle Group Inc. | 4.10 | -96.00 | |
13G/A | Pfizer Inc | 3.47 | 0.00 | |
13G/A | Sectoral Asset Management Inc | 3.70 | 0.00 | |
13G/A | Sr One Capital Management, Llc | 0.00 | -100.00 | |
13G/A | Altitude Life Science Ventures Fund II, L.P. | 4.40 | 0.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Similar Companies | |
---|---|
DSKYF – Daiichi Sankyo Company, Limited | EAPH – Parallel Industries Inc. |
EAPIF – Euroapi S.A. | EGRX – Eagle Pharmaceuticals, Inc. |
ELOX – Eloxx Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io